Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contribution of Orexin to the Neurogenic Hypertension in BPH/2J Mice
Kristy L. Jackson, Bruno W. Dampney, John‐Luis Moretti, et al.
Hypertension (2016) Vol. 67, Iss. 5, pp. 959-969
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Neuronal Networks in Hypertension
Patrice G. Guyenet, Ruth L. Stornetta, George M. P. R. Souza, et al.
Hypertension (2020) Vol. 76, Iss. 2, pp. 300-311
Open Access | Times Cited: 75
Cardiovascular disorders in narcolepsy: Review of associations and determinants
Poul Jennum, Giuseppe Plazzi, Alessandro Silvani, et al.
Sleep Medicine Reviews (2021) Vol. 58, pp. 101440-101440
Open Access | Times Cited: 52
Role of Orexin-A in Hypertension and Obesity
Roberta Imperatore, Letizia Palomba, Luigia Cristino
Current Hypertension Reports (2017) Vol. 19, Iss. 4
Closed Access | Times Cited: 57
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases
Alberto Giannoni, Chiara Borrelli, Francesco Gentile, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 5, pp. 642-656
Open Access | Times Cited: 15
Orexin and Central Modulation of Cardiovascular and Respiratory Function
Pascal Carrive, Tomoyuki Kuwaki
Current topics in behavioral neurosciences (2016), pp. 157-196
Open Access | Times Cited: 45
Pharmacological and psychological approaches to insomnia treatment in cardiac patients: a narrative literature review
Britta Stapel, Marlies Alvarenga, Kai G. Kahl
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage
Jaideep Singh, Kristy L. Jackson, Haoyun Fang, et al.
Cardiovascular Research (2024)
Open Access | Times Cited: 3
Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice
Kristy L. Jackson, Geoffrey A. Head, Cindy Gueguen, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 29
An augmented CO2 chemoreflex and overactive orexin system are linked with hypertension in young and adult spontaneously hypertensive rats
Aihua Li, Sarah Roy, Eugene Nattie
The Journal of Physiology (2016) Vol. 594, Iss. 17, pp. 4967-4980
Open Access | Times Cited: 28
The role of sleep disorders in cardiovascular diseases: Culprit or accomplice?
Qianwen Wang, Xi Wang, Chun Yang, et al.
Life Sciences (2021) Vol. 283, pp. 119851-119851
Closed Access | Times Cited: 23
Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders
Hiroshi Tsuneki, Tsutomu Wada, Toshiyasu Sasaoka
Pharmacology & Therapeutics (2017) Vol. 186, pp. 25-44
Closed Access | Times Cited: 28
The Orexin System and Hypertension
Michael Huber, Qing‐Hui Chen, Zhiying Shan
Cellular and Molecular Neurobiology (2017) Vol. 38, Iss. 2, pp. 385-391
Open Access | Times Cited: 27
Orexin A increases sympathetic nerve activity through promoting expression of proinflammatory cytokines in Sprague Dawley rats
Yuan Fan, Enshe Jiang, Taija Hahka, et al.
Acta Physiologica (2017) Vol. 222, Iss. 2
Open Access | Times Cited: 27
Orexin, Stress and Central Cardiovascular Control. A Link with Hypertension?
Pascal Carrive
Neuroscience & Biobehavioral Reviews (2016) Vol. 74, pp. 376-392
Closed Access | Times Cited: 26
Orexins, Sleep, and Blood Pressure
Mariusz Siemiński, Jacek Szypenbejl, Eemil Partinen
Current Hypertension Reports (2018) Vol. 20, Iss. 9
Open Access | Times Cited: 25
Orexin in Respiratory and Autonomic Regulation, Health and Diseases
Savannah Barnett, Aihua Li
Comprehensive physiology (2020), pp. 345-363
Closed Access | Times Cited: 20
Cardiovascular pressor effects of orexins in the dorsomedial hypothalamus
Tzu-Ling Li, Jennifer Y.S. Chen, Shang-Cheng Huang, et al.
European Journal of Pharmacology (2017) Vol. 818, pp. 343-350
Closed Access | Times Cited: 19
Orexin, Sleep, Sympathetic Neural Activity, and Cardiovascular Function
Jeremy A. Bigalke, Zhiying Shan, Jason R. Carter
Hypertension (2022) Vol. 79, Iss. 12, pp. 2643-2655
Open Access | Times Cited: 10
Role of medial hypothalamic orexin system in panic, phobia and hypertension
Aline Rezende Abreu, Andrei I. Molosh, Philip L. Johnson, et al.
Brain Research (2018) Vol. 1731, pp. 145942-145942
Open Access | Times Cited: 18
Implicating the potential role of orexin in hypertension
Monika Rani, Raghuvansh Kumar, Pawan Krishan
Naunyn-Schmiedeberg s Archives of Pharmacology (2017) Vol. 390, Iss. 7, pp. 667-676
Closed Access | Times Cited: 15
Neural suppression of miRNA-181a in the kidney elevates renin expression and exacerbates hypertension in Schlager mice
Kristy L. Jackson, Cindy Gueguen, Kyungjoon Lim, et al.
Hypertension Research (2020) Vol. 43, Iss. 11, pp. 1152-1164
Closed Access | Times Cited: 14
Endothelial transcriptomics reveals activation of fibrosis-related pathways in hypertension
Jonathan W. Nelson, Mohammed Z. Ferdaus, James A. McCormick, et al.
Physiological Genomics (2017) Vol. 50, Iss. 2, pp. 104-116
Open Access | Times Cited: 11
Exploring a New Natural Treating Agent for Primary Hypertension: Recent Findings and Forthcoming Perspectives
Shian‐Ren Lin, Shiuan‐Yea Lin, Ching‐Cheng Chen, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 11, pp. 2003-2003
Open Access | Times Cited: 10
Deletion of Orphan G Protein-Coupled Receptor GPR37L1 in Mice Alters Cardiovascular Homeostasis in a Sex-Specific Manner
Margaret A. Mouat, Kristy L. Jackson, James L. J. Coleman, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top